NCT03295396 2025-07-28
ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
Jazz Pharmaceuticals
Phase 2 Terminated
Clinical Trials
5 trialsNCT02525692 2024-12-24
Oral ONC201 in Adult Recurrent Glioblastoma
Jazz Pharmaceuticals
Phase 2 Terminated
NCT03099499 2024-12-24
Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
Fox Chase Cancer Center
Phase 2 Terminated
NCT03485729 2024-12-24
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
Jazz Pharmaceuticals
Phase 2 Terminated
NCT03733119 2022-03-10
ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer
University of Wisconsin, Madison
Phase 2 Terminated